Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bock

Showing results (291-300 of 300) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 300 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 9, 2025
Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trialEllen R Bradley, Kimberly Sakai, Gisele Fernandes-Osterhold, et al.
Nature Communications|December 15, 2023
Identification of 5-HT<sub>2A</sub> receptor signaling pathways associated with psychedelic potentialJason Wallach, Andrew B Cao, Maggie M Calkins, et al.
Biorxiv : the Preprint Server for Biology|August 14, 2023
Identification of 5-HT<sub>2A</sub> Receptor Signaling Pathways Responsible for Psychedelic PotentialJason Wallach, Andrew B Cao, Maggie M Calkins, et al.
Journal of Medicinal Chemistry|November 26, 2024
Potent and Selective Human 5-HT<sub>2B</sub> Serotonin Receptor Antagonists: 4'-Cyano-(N)-methanocarba-adenosines by Synthetic SerendipityDilip K Tosh, Matteo Pavan, Allison A Clark, et al.
Science Advances|December 8, 2021
Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrenceDavid Bakhshinyan, Ashley A Adile, Jeff Liu, et al.
Journal of Cardiovascular Translational Research|July 22, 2015
A Robust e-Epidemiology Tool in Phenotyping Heart Failure with Differentiation for Preserved and Reduced Ejection Fraction: the Electronic Medical Records and Genomics (eMERGE) NetworkSuzette J Bielinski, Jyotishman Pathak, David S Carrell, et al.
International Journal of Biomedical Data Mining|April 8, 2016
ePhenotyping for Abdominal Aortic Aneurysm in the Electronic Medical Records and Genomics (eMERGE) Network: Algorithm Development and Konstanz Information Miner WorkflowKenneth M Borthwick, Diane T Smelser, Jonathan A Bock, et al.
Physical Review Letters|May 21, 2005
Measurement of helicity-dependent photoabsorption cross sections on the neutron from 815 to 1825 MeVH Dutz, K Helbing, J Krimmer, et al.
Physical Review Letters|November 13, 2003
First Measurement of the Gerasimov-Drell-Hearn Sum Rule for 1H from 0.7 to 1.8 GeV at ELSAH Dutz, K Helbing, J Krimmer, et al.
Physical Review Letters|August 25, 2004
Experimental check of the Gerasimov-Drell-Hearn sum rule for 1HH Dutz, K Helbing, J Krimmer, et al.
Pageof 30

Showing results (291-300 of 300) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 300 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 9, 2025
Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trialEllen R Bradley, Kimberly Sakai, Gisele Fernandes-Osterhold, et al.
Nature Communications|December 15, 2023
Identification of 5-HT<sub>2A</sub> receptor signaling pathways associated with psychedelic potentialJason Wallach, Andrew B Cao, Maggie M Calkins, et al.
Biorxiv : the Preprint Server for Biology|August 14, 2023
Identification of 5-HT<sub>2A</sub> Receptor Signaling Pathways Responsible for Psychedelic PotentialJason Wallach, Andrew B Cao, Maggie M Calkins, et al.
Journal of Medicinal Chemistry|November 26, 2024
Potent and Selective Human 5-HT<sub>2B</sub> Serotonin Receptor Antagonists: 4'-Cyano-(N)-methanocarba-adenosines by Synthetic SerendipityDilip K Tosh, Matteo Pavan, Allison A Clark, et al.
Science Advances|December 8, 2021
Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrenceDavid Bakhshinyan, Ashley A Adile, Jeff Liu, et al.
Journal of Cardiovascular Translational Research|July 22, 2015
A Robust e-Epidemiology Tool in Phenotyping Heart Failure with Differentiation for Preserved and Reduced Ejection Fraction: the Electronic Medical Records and Genomics (eMERGE) NetworkSuzette J Bielinski, Jyotishman Pathak, David S Carrell, et al.
International Journal of Biomedical Data Mining|April 8, 2016
ePhenotyping for Abdominal Aortic Aneurysm in the Electronic Medical Records and Genomics (eMERGE) Network: Algorithm Development and Konstanz Information Miner WorkflowKenneth M Borthwick, Diane T Smelser, Jonathan A Bock, et al.
Physical Review Letters|May 21, 2005
Measurement of helicity-dependent photoabsorption cross sections on the neutron from 815 to 1825 MeVH Dutz, K Helbing, J Krimmer, et al.
Physical Review Letters|November 13, 2003
First Measurement of the Gerasimov-Drell-Hearn Sum Rule for 1H from 0.7 to 1.8 GeV at ELSAH Dutz, K Helbing, J Krimmer, et al.
Physical Review Letters|August 25, 2004
Experimental check of the Gerasimov-Drell-Hearn sum rule for 1HH Dutz, K Helbing, J Krimmer, et al.
Pageof 30